Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Third positive trial sets up filings for AbbVie’s Rinvoq in Crohn’s
Pharmaforum
Thu, 05/12/22 - 10:46 am
AbbVie
Rinvoq
clinical trials
Crohn’s disease
AbbVie, Teva looking to settle nationwide opioid litigation for $5B+: Bloomberg
Fierce Pharma
Wed, 05/11/22 - 11:05 pm
AbbVie
Allergan
Teva Pharmaceutical
opioids
opioid crisis
legal
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
biotech
life sciences
hirings
Regeneron
Pfizer
Amgen
AbbVie
Moderna Therapeutics
CSL Behring
Waters Corporation
Daiichi Sankyo
Gilead Sciences
Grail
Emergent BioSolutions
resilience
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
Endpoints
Thu, 05/5/22 - 11:34 pm
Biogen
earnings
SEC
Eli Lilly
Merck
Bristol Myers Squibb
Pfizer
AbbVie
AbbVie's red-hot Rinvoq scores fourth FDA approval in five months
Fierce Pharma
Sat, 04/30/22 - 02:34 pm
AbbVie
Rinvoq
FDA
ankylosing spondylitis
AbbVie's Q1 Good News That Investors Could Be Missing
Motley Fool
Sat, 04/30/22 - 02:31 pm
AbbVie
Humira
earnings
Allergan
More molecular glue: Plexium pens AbbVie pact months after Amgen deal
Endpoints
Thu, 04/28/22 - 10:59 am
Plexium
molecular glue
AbbVie
targeted protein degradation
neurological disorders
Pharma Continues to Support Ukraine as War Rages On
BioSpace
Fri, 04/22/22 - 10:40 am
Russia
Ukraine
AbbVie
Novartis
Pfizer
First-quarter biotech risers work hard for the win
EP Vantage
Thu, 04/21/22 - 10:32 am
biotech
AbbVie
Bayer
Ipsen
Lantheus Medical
AbbVie shreds alpha-synuclein Parkinson's pact on cusp of phase 2, thinning field led by Roche
Fierce Biotech
Wed, 04/20/22 - 10:59 am
AbbVie
Parkinson's Disease
alpha-synuclein
clinical trials
ABBV-0805
Outside of big pharma, life remains tough for listed developers
EP Vantage
Wed, 04/20/22 - 10:38 am
pharma stocks
AbbVie
AstraZeneca
BeiGene
BioNTech
Moderna Therapeutics
Pfizer
Roche
AbbVie takes next step in Ukraine, donating all Russia profits to relief
Endpoints
Tue, 04/19/22 - 11:39 pm
AbbVie
Ukraine
Russia
Takeover-driven resurgence fails to materialize for biotech
EP Vantage
Thu, 04/14/22 - 10:41 am
M&A
AbbVie
Biocon
Biogen
Biohaven
GSK
Halozyme Therapeutics
Samsung Bioepis
UCB
Viatris
AbbVie preps filings for lymphoma bispecific licensed from Genmab
Pharmaforum
Thu, 04/14/22 - 10:39 am
AbbVie
Genmab
cancer
epcoritamab
large B-cell lymphoma
AACR: AbbVie's navitoclax goes after tough blood cancer, not yet reaching overall survival benchmark
Fierce Biotech
Tue, 04/12/22 - 08:31 pm
AACR
AbbVie
navitoclax
myelofibrosis
blood cancer
US Congress proposes bills to strengthen pharma competition, promote innovation
BioSpace
Fri, 04/8/22 - 10:49 am
congress
legislation
competition
innovation
AbbVie
In a year of big growth for AbbVie, CEO Richard Gonzalez scored $24M pay package
Fierce Pharma
Thu, 03/31/22 - 10:44 am
AbbVie
Richard Gonzalez
executive pay
Pharma CEOs
Teva, AbbVie ink opioid settlements worth nearly $330M with Florida
Fierce Pharma
Thu, 03/31/22 - 10:25 am
Teva Pharmaceutical
AbbVie
legal
Florida
opioids
opioid crisis
Ahead of Humira's patent cliff, AbbVie's Rinvoq notches third new use in 4 months
Fierce Pharma
Thu, 03/17/22 - 11:33 pm
AbbVie
Rinvoq
ulcerative colitis
FDA
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »